Stock listing
NASDAQ:PAHC Phibro Animal Health Corporation Stock
Home listing (NASDAQ) of Phibro Animal Health Corporation
Follow Phibro Animal Health Corporation into a list and get an email when it puts out news.
Share price · NASDAQ:PAHC
$33.29 USD -2.28 (-6.4%)
Close on Nov 20, 2026
- Day range
- $33.27 – $34.54 USDNov 20, 2026
- Volume
- 155,540 sharesNov 20, 2026
- Market cap
- $702.6M USDAt the close on Nov 20, 2026 · price × 21.11M shares outstanding
- 52-week range
- $28.25 – $60.08 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $8.48M USDMedian day 205,851 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PAHC · Home | $33.29 USD | -2.28 (-6.4%) | 155,540 | $34.01 | $34.54 | $33.27 | $35.57 | Close on Nov 20, 2026 |
| Frankfurt:PB8 | €30.80 EUR | -1.20 (-3.7%) | — | €30.80 | €30.80 | €30.80 | €32.00 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PAHC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $33.29 | -2.28 | -6.4% | $34.01 | $34.54 | $33.27 | 155,540 | |
| $35.57 | +0.65 | +1.9% | $34.56 | $35.74 | $34.50 | 109,170 | |
| $34.92 | -0.10 | -0.3% | $34.90 | $35.64 | $34.26 | 130,088 | |
| $35.02 | -0.95 | -2.6% | $36.04 | $36.08 | $34.84 | 193,568 | |
| $35.97 | +0.51 | +1.4% | $35.69 | $36.40 | $35.15 | 293,913 | |
| $35.46 | +0.31 | +0.9% | $35.19 | $35.51 | $34.79 | 130,125 | |
| $35.15 | +0.51 | +1.5% | $34.58 | $35.30 | $34.28 | 145,577 | |
| $34.64 | +0.03 | +0.1% | $34.48 | $35.24 | $33.98 | 223,790 | |
| $34.61 | +1.65 | +5.0% | $33.33 | $35.03 | $33.07 | 282,679 | |
| $32.96 | -2.44 | -6.9% | $35.21 | $35.67 | $32.91 | 283,624 | |
| $35.40 | -4.03 | -10.2% | $38.09 | $39.46 | $35.00 | 348,693 | |
| $39.43 | +1.78 | +4.7% | $38.61 | $39.72 | $38.32 | 266,658 | |
| $37.65 | -1.09 | -2.8% | $38.93 | $39.53 | $37.35 | 289,490 | |
| $38.74 | -0.14 | -0.4% | $39.41 | $40.54 | $38.05 | 250,434 | |
| $38.88 | +0.02 | +0.1% | $39.38 | $39.95 | $38.49 | 182,782 | |
| $38.86 | +0.98 | +2.6% | $38.35 | $39.01 | $38.28 | 100,824 | |
| $37.88 | -0.50 | -1.3% | $38.18 | $38.46 | $37.60 | 168,858 | |
| $38.38 | -0.65 | -1.7% | $38.95 | $39.26 | $38.30 | 118,865 | |
| $39.03 | +0.23 | +0.6% | $38.80 | $39.57 | $38.70 | 144,643 | |
| $38.80 | -1.01 | -2.5% | $39.51 | $39.51 | $38.62 | 102,861 | |
| $39.81 | +0.56 | +1.4% | $39.37 | $40.87 | $39.28 | 254,380 | |
| $39.25 | +0.45 | +1.2% | $38.74 | $39.36 | $38.11 | 169,199 | |
| $38.80 | -0.54 | -1.4% | $39.34 | $39.99 | $38.78 | 153,529 | |
| $39.34 | +0.52 | +1.3% | $39.12 | $39.81 | $38.53 | 184,836 | |
| $38.82 | +0.84 | +2.2% | $38.04 | $38.94 | $37.24 | 186,997 | |
| $37.98 | +0.05 | +0.1% | $38.19 | $39.64 | $37.83 | 184,696 | |
| $37.93 | +1.12 | +3.0% | $36.53 | $38.33 | $36.53 | 283,078 | |
| $36.81 | -0.62 | -1.7% | $37.75 | $37.89 | $36.70 | 407,386 | |
| $37.43 | -0.87 | -2.3% | $38.28 | $38.65 | $37.05 | 205,851 | |
| $38.30 | +0.90 | +2.4% | $37.40 | $39.26 | $37.40 | 235,919 | |
| $37.40 | -0.32 | -0.8% | $37.53 | $37.58 | $36.72 | 238,731 | |
| $37.72 | +1.11 | +3.0% | $36.43 | $37.93 | $36.03 | 199,528 | |
| $36.61 | -0.58 | -1.6% | $37.46 | $37.70 | $36.31 | 133,228 | |
| $37.19 | -0.05 | -0.1% | $37.14 | $38.05 | $37.05 | 280,031 | |
| $37.24 | +1.37 | +3.8% | $36.19 | $37.62 | $36.19 | 222,743 | |
| $35.87 | +0.13 | +0.4% | $35.58 | $36.23 | $35.18 | 275,073 | |
| $35.74 | +0.29 | +0.8% | $35.68 | $36.02 | $35.06 | 205,543 | |
| $35.45 | -0.25 | -0.7% | $35.46 | $35.72 | $34.70 | 170,540 | |
| $35.70 | +1.25 | +3.6% | $34.25 | $36.13 | $33.84 | 485,902 | |
| $34.45 | +0.52 | +1.5% | $33.93 | $34.66 | $33.52 | 206,583 | |
| $33.93 | -0.17 | -0.5% | $34.10 | $34.25 | $33.05 | 130,577 | |
| $34.10 | -1.05 | -3.0% | $35.14 | $36.04 | $34.04 | 141,670 | |
| $35.15 | +0.47 | +1.4% | $35.10 | $35.54 | $34.91 | 204,028 | |
| $34.68 | +0.12 | +0.3% | $34.71 | $35.39 | $34.46 | 141,339 | |
| $34.56 | +0.115 | +0.3% | $34.12 | $35.11 | $34.12 | 635,514 | |
| $34.45 | -0.855 | -2.4% | $35.64 | $35.64 | $34.40 | 212,035 | |
| $35.30 | +0.27 | +0.8% | $35.03 | $35.98 | $34.68 | 269,516 | |
| $35.03 | -0.91 | -2.5% | $36.00 | $36.00 | $34.94 | 322,822 | |
| $35.94 | +0.32 | +0.9% | $35.92 | $36.70 | $35.84 | 258,359 | |
| $35.62 | -0.96 | -2.6% | $36.99 | $37.66 | $35.51 | 212,300 | |
| $36.58 | -0.22 | -0.6% | $36.80 | $36.96 | $36.30 | 174,057 | |
| $36.80 | -0.51 | -1.4% | $37.11 | $37.46 | $36.60 | 176,890 | |
| $37.31 | -0.94 | -2.5% | $37.92 | $37.92 | $36.86 | 182,186 | |
| $38.25 | -0.33 | -0.9% | $38.26 | $38.82 | $37.69 | 176,418 | |
| $38.58 | -1.34 | -3.4% | $40.24 | $40.50 | $38.20 | 174,643 | |
| $39.92 | +1.55 | +4.0% | $38.32 | $40.65 | $38.32 | 324,242 | |
| $38.37 | +0.63 | +1.7% | $37.77 | $38.72 | $37.63 | 370,174 | |
| $37.74 | +0.07 | +0.2% | $37.13 | $38.07 | $36.72 | 357,376 | |
| $37.67 | +1.32 | +3.6% | $36.36 | $38.65 | $36.36 | 362,753 | |
| $36.35 | +0.26 | +0.7% | $39.39 | $39.39 | $35.01 | 432,907 | |
| $36.09 | +0.16 | +0.4% | $36.48 | $36.79 | $35.74 | 300,600 | |
| $35.93 | +0.62 | +1.8% | $35.71 | $36.11 | $35.30 | 236,800 | |
| $35.31 | -1.01 | -2.8% | $36.32 | $36.74 | $35.11 | 153,191 | |
| $36.32 | +1.14 | +3.2% | $35.41 | $36.44 | $35.29 | 324,420 | |
| $35.18 | -0.26 | -0.7% | $35.26 | $35.89 | $34.63 | 179,333 |
- Ticker
- NASDAQ:PAHC
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 4, 2026
Phibro Animal Health Corporation Reports First Quarter Results, Maintains Financial Guidance
Latest earnings call · Nov 5, 2026
Phibro Animal Health (NASDAQ:PAHC) Q1 2027 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q1 FY2027 Earnings Presentation
Earnings · 9 slides
Latest news
Phibro Animal Health Corporation Reports First Quarter Results, Maintains Financial Guidance
Nov 4, 2026
Closed $35.40 (-10.2%) on Nov 5, 2026
Phibro Animal Health Corporation Declares Quarterly Dividend
Nov 3, 2026
Closed $39.43 (+4.7%) on Nov 4, 2026
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
Oct 28, 2026
Closed $38.86 (+2.6%) on Oct 29, 2026
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference
Sep 9, 2026
Closed $36.58 (-0.6%) on Sep 10, 2026
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results
Aug 19, 2026
Closed $35.18 (-0.7%) on Aug 20, 2026
Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference
May 21, 2026
Closed $33.26 (-0.6%) on May 22, 2026
Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference
May 7, 2026
Closed $40.00 (-7.3%) on May 8, 2026
Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership
May 6, 2026
Closed $58.50 (+4.0%) on May 6, 2026
Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials
Apr 27, 2026
Closed $56.14 (+1.8%) on Apr 27, 2026
Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit
Feb 18, 2026
Closed $51.85 (+1.5%) on Feb 19, 2026
Phibro Animal Health Corporation on 6ix
- News releases
- 15 in the last 12 months · 89 in all · newest Nov 4, 2026 · oldest 2019
- Calls
- 25 calls with a replay · 25 with a transcript · latest Nov 5, 2026
- Decks
- 42 decks · latest Nov 5, 2026
Where Phibro Animal Health Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PAHC · Home listing · This page | NASDAQ | United States | USD |
| gettex:PB8 | gettex | Germany | EUR |
| LS Exchange:A1WZ6P | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1WZ6P | Lang & Schwarz | Germany | EUR |
| BOATS:PAHC | BOATS | United States | USD |
| Dusseldorf:PB8 | Dusseldorf | Germany | EUR |
| Frankfurt:PB8 | Frankfurt | Germany | EUR |
| Tradegate:PB8 | Tradegate | Germany | EUR |
| Munich:PB8 | Munich | Germany | EUR |
| Stuttgart:PB8 | Stuttgart | Germany | EUR |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.23B USD
- P/E
- 6.8×
- EV/sales
- 0.8×
- EV/EBITDA
- 5.0×
- Price/book
- 1.7×
- Gross margin
- 33.8%
- Operating margin
- 12.5%
- Net margin
- 6.7%
- Debt to equity
- 1.5×
- Beta vs S&P 500
- 0.96
Forecasts
1 buy · 2 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 47.00 USD · Analysts' mean
- EPS, year to Jun 2027
- 3.48 · 3 analysts
- Revenue, year to Jun 2027
- 1.58B · 3 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Daniel M. Bendheim | President and Chief Executive Officer |
| Glenn David | Chief Financial Officer |
| Larry L. Miller | Chief Operating Officer |
| Judith A. Weinstein | Senior Vice President, General Counsel and Corporate Secretary |
| Jonathan Bendheim | Executive Vice President, Talent, Technology and Business Development |
| Lisa A. Escudero | Senior Vice President, Human Resources |
| Mona Desai | Vice President and Corporate Controller |
| Patrick Rodriguez | Vice President Finance and Treasurer |
| Jack C. Bendheim | Executive Chairman and Chairman of the Board of Directors |
Board
| Director | Role |
|---|---|
| Jack C. Bendheim | Executive Chairman and Chairman of the Board of Directors |
Events
Calls
| Call | When | Status |
|---|---|---|
| Phibro Animal Health (NASDAQ:PAHC) Q1 2027 Earnings Call | Thu, Nov 05, 2026 · 9:00 AM ET | Replay |
| Phibro Animal Health (NASDAQ:PAHC) Q4 2026 Earnings Call | Thu, Aug 27, 2026 · 9:00 AM ET | Replay |
| Phibro Animal Health (NASDAQ:PAHC) Q3 2026 Earnings Call | Thu, May 07, 2026 · 9:00 AM ET | Replay |
| Phibro Animal Health (NASDAQ:PAHC) Q2 2026 Earnings Call | Thu, Feb 05, 2026 · 9:00 AM ET | Replay |
| Phibro Animal Health (NASDAQ:PAHC) Q1 2026 Earnings Call | Thu, Nov 06, 2025 · 9:00 AM ET | Replay |
| Phibro Animal Health (NASDAQ:PAHC) Q4 2025 Earnings Call | Thu, Aug 28, 2025 · 9:00 AM ET | Replay |
| Phibro Animal Health (NASDAQ:PAHC) Q3 2025 Earnings Call | Thu, May 08, 2025 · 9:00 AM ET | Replay |
| Phibro Animal Health (NASDAQ:PAHC) Q2 2025 Earnings Call | Thu, Feb 06, 2025 · 9:00 AM ET | Replay |
| Phibro Animal Health (NASDAQ:PAHC) Q1 2025 Earnings Call | Thu, Nov 07, 2024 · 9:00 AM ET | Replay |
| Phibro Animal Health (NASDAQ:PAHC) Q4 2024 Earnings Call | Thu, Aug 29, 2024 · 9:00 AM ET | Replay |
All 25 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q1 2027 | Nov 4, 2026 · After close | −10.2% |
| Q4 2026 | Aug 26, 2026 · After close | +0.7% |
| Q3 2026 | May 6, 2026 · After close | −26.2% |
| Q2 2026 | Feb 4, 2026 · After close | +21.9% |
| Q1 2026 | Nov 5, 2025 · After close | +4.6% |
| Q4 2025 | Aug 27, 2025 | +17.8% |
| Q3 2025 | May 7, 2025 · After close | +14.8% |
| Q2 2025 | Feb 5, 2025 · After close | +9.9% |
| Q1 2025 | Nov 6, 2024 · After close | +1.8% |
| Q4 2024 | Aug 28, 2024 · Before open | −1.2% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2024 | May 8, 2024 · After close | +3.0% |
| Q2 2024 | Feb 7, 2024 · After close | +7.4% |
| Q1 2024 | Nov 8, 2023 · After close | −18.5% |
| Q4 2023 | Aug 30, 2023 · After close | −5.9% |
| Q3 2023 | May 3, 2023 · After close | −8.3% |
| Q2 2023 | Feb 8, 2023 · After close | 0.0% |
| Q1 2023 | Nov 9, 2022 · After close | −3.0% |
| Q4 2022 | Aug 24, 2022 · After close | −5.6% |
| Q3 2022 | May 4, 2022 · After close | −9.1% |
| Q2 2022 | Feb 9, 2022 · After close | +7.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 FY2027 Earnings Presentation | Earnings | 9 slides | Nov 5, 2026 |
| Q4 2026 Earnings Presentation | Earnings | 12 slides | Aug 27, 2026 |
| Q3 2026 Earnings Presentation | Earnings | 9 slides | May 7, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 9 slides | Feb 5, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 9 slides | Nov 6, 2025 |
| Q4 2025 Earnings Presentation | Earnings | 12 slides | Aug 28, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 9 slides | May 8, 2025 |
| Q2 FY2025 Earnings Presentation | Earnings | 9 slides | Feb 6, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 10 slides | Nov 7, 2024 |
| Q4 2024 Earnings Presentation | Earnings | 13 slides | Aug 29, 2024 |
All 42 decks
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.52B | 1.30B | 1.02B | 977.9M | 942.3M | 833.4M | 800.4M | 828.0M | 820.0M | 764.3M |
| Cost of revenue | 1.01B | 896.3M | 704.6M | 679.7M | 656.9M | 562.0M | 543.5M | 563.4M | 553.1M | 516.0M |
| Gross profit | 512.5M | 399.9M | 313.1M | 298.2M | 285.4M | 271.4M | 256.9M | 264.6M | 266.9M | 248.2M |
| Research and development | 24.6M | 23.7M | 29.2M | 24.4M | 20.8M | 17.8M | 13.7M | 12.1M | 10.00M | 9.44M |
| Selling, general and administrative | 318.1M | 289.5M | 259.8M | 226.4M | 206.4M | 196.5M | 187.7M | 181.4M | 168.0M | 150.3M |
| Operating income | 194.4M | 110.5M | 53.3M | 71.8M | 79.0M | 74.9M | 69.2M | 83.2M | 98.9M | 97.9M |
| Depreciation and amortization | 51.5M | 45.6M | 36.2M | 34.0M | 32.7M | 31.9M | 32.3M | 27.6M | 26.9M | 26.0M |
| EBITDA | 245.9M | 156.1M | 89.5M | 105.9M | 111.7M | 106.8M | 101.5M | 110.8M | 125.9M | 123.9M |
| Interest expense | 46.4M | 37.2M | 23.0M | 18.7M | 12.7M | 13.7M | 14.6M | 13.7M | 13.6M | 16.9M |
| Income before tax | 137.3M | 68.0M | 10.9M | 54.1M | 72.3M | 66.5M | 55.5M | 71.5M | 88.1M | 80.5M |
| Income tax | 37.6M | 19.7M | 8.50M | 21.5M | 23.2M | 12.1M | 22.0M | 16.8M | 23.2M | 15.9M |
| Net income | 99.7M | 48.3M | 2.42M | 32.6M | 49.2M | 54.4M | 33.6M | 54.7M | 64.9M | 64.6M |
| Earnings per share, basic | 2.46 | 1.19 | 0.06 | 0.81 | 1.21 | 1.34 | 0.83 | 1.35 | 1.61 | 1.63 |
| Earnings per share, diluted | 2.43 | 1.19 | 0.06 | 0.81 | 1.21 | 1.34 | 0.83 | 1.35 | 1.61 | 1.61 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 61.4M | 68.0M | 70.6M | 41.3M | 74.2M | 50.2M | 36.3M | 57.6M | 29.2M | 56.1M |
| Short-term investments | 20.6M | 9.00M | 44.0M | 40.0M | 17.0M | 43.0M | 55.0M | 24.0M | 50.0M | 2.69M |
| Receivables | 238.8M | 228.0M | 169.5M | 163.5M | 166.5M | 146.9M | 126.5M | 159.0M | 135.7M | 125.8M |
| Inventory | 534.9M | 444.4M | 265.9M | 277.6M | 259.2M | 216.3M | 196.7M | 198.3M | 178.2M | 161.2M |
| Current assets | 935.5M | 810.6M | 601.0M | 585.7M | 566.2M | 498.9M | 451.8M | 466.2M | 415.5M | 363.7M |
| Property, plant and equipment | 369.2M | 354.7M | 203.3M | 195.6M | 165.5M | 154.7M | 148.1M | 140.2M | 130.1M | 127.4M |
| Goodwill | 60.0M | 59.6M | 54.6M | 53.3M | 53.2M | 52.7M | 52.7M | 27.3M | 27.3M | 24.0M |
| Total assets | 1.50B | 1.36B | 982.2M | 971.4M | 931.7M | 841.3M | 784.1M | 726.7M | 671.7M | 623.4M |
| Accounts payable | 127.3M | 138.2M | 85.6M | 73.9M | 95.6M | 68.4M | 66.1M | 73.2M | 59.5M | 56.9M |
| Current liabilities | 316.5M | 293.5M | 204.1M | 176.0M | 190.8M | 164.1M | 157.2M | 154.2M | 143.2M | 115.8M |
| Long-term debt | 591.8M | 615.4M | 282.3M | 311.5M | 272.9M | 297.1M | 218.0M | 217.6M | 229.8M | 241.9M |
| Total debt | 616.8M | 631.7M | 312.1M | 333.8M | 287.9M | 298.1M | 218.8M | 231.3M | 243.9M | 250.0M |
| Total liabilities | 1.12B | 1.08B | 725.5M | 688.9M | 669.3M | 602.8M | 595.9M | 510.7M | 486.7M | 472.2M |
| Shareholders' equity | 385.5M | 285.7M | 256.6M | 282.5M | 262.4M | 238.5M | 188.2M | 216.0M | 185.0M | 151.2M |
| Shares outstanding | 41.0M | 40.7M | 40.5M | 40.5M | 40.5M | 40.5M | 40.5M | 40.5M | 40.4M | 40.0M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 69.0M | 80.1M | 87.6M | 13.3M | 31.6M | 48.3M | 59.3M | 47.2M | 70.0M | 98.4M |
| Capital spending | -59.1M | -38.3M | -41.2M | -51.8M | -37.0M | -29.3M | -34.0M | -29.9M | -18.5M | -20.9M |
| Free cash flow | 9.87M | 41.8M | 46.4M | -38.5M | -5.39M | 19.0M | 25.3M | 17.3M | 51.5M | 77.5M |
| Cash from investing | -71.5M | -288.7M | -48.2M | -74.0M | -22.6M | -18.6M | -120.4M | -14.1M | -84.6M | -21.9M |
| Cash from financing | -6.56M | 207.1M | -6.77M | 27.0M | 16.3M | -17.0M | 40.9M | -4.11M | -11.8M | -53.7M |
| Dividends paid | -19.5M | -19.4M | -19.4M | -19.4M | -19.4M | -19.4M | -19.4M | -18.6M | -16.1M | -15.8M |
| Share buybacks | 1.13M | 5.70M | 480.5M | |||||||
| Change in cash | -6.62M | -2.57M | 29.3M | -33.0M | 24.0M | 13.9M | -21.2M | 28.4M | -26.9M | 22.5M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 4, 2026 | Results | SEC |
| 10-Q · Quarterly report | Nov 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 3, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 19, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Sep 18, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Sep 18, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Sep 18, 2026 | Meeting notice | SEC |
| 4/A · Change in ownership, amended | Sep 17, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Sep 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 16, 2026 | Other filings | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Aug 26, 2026 | Results | SEC |
| 10-K · Annual report | Aug 26, 2026 | Annual report | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 6, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 30, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jul 28, 2026 | Current report | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 26, 2026 | Management or board change | SEC |
| 144 · Notice of proposed sale | Jun 16, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 2, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | May 22, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 7, 2026 | Insider trade | SEC |
| 8-K · Current report | May 6, 2026 | Results | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Current report | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| 8-K · Current report | Apr 30, 2026 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Apr 27, 2026 | Current report | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Apr 23, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 16, 2026 | Insider trade | SEC |
| 8-K · Current report | Apr 14, 2026 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 7, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 31, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 13, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 11, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 11, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 11, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2026 | Insider trade | SEC |
| 8-K · Current report | Feb 4, 2026 | Results | SEC |
| 10-Q · Quarterly report | Feb 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Feb 3, 2026 | Current report | SEC |
| 4 · Change in ownership | Feb 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 22, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 8, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 18, 2025 | Management or board change | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Dec 15, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 4, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 6, 2025 | Insider trade | SEC |
| 8-K · Current report | Nov 5, 2025 | Results | SEC |
| 10-Q · Quarterly report | Nov 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2025 | Current report | SEC |
| 4 · Change in ownership | Oct 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 22, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Sep 19, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Sep 19, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Sep 19, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Sep 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 4, 2025 | Other filings | SEC |
| 8-K · Current report | Aug 27, 2025 | Results | SEC |
| 10-K · Annual report | Aug 27, 2025 | Annual report | SEC |
| 144 · Notice of proposed sale | Aug 19, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 29, 2025 | Current report | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jun 3, 2025 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | May 19, 2025 | Other filings | SEC |
| 8-K · Current report | May 7, 2025 | Results | SEC |
| 10-Q · Quarterly report | May 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 28, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 28, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 18, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 11, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 5, 2025 | Results | SEC |
| 10-Q · Quarterly report | Feb 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Feb 4, 2025 | Current report | SEC |
| 3 · Initial statement of ownership | Jan 28, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 23, 2025 | Management or board change | SEC |
| 8-K/A · Current report, amended | Jan 7, 2025 | Current report | SEC |
| SC 13D/A · Big-stake notice, amended | Nov 15, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 12, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Nov 12, 2024 | Management or board change | SEC |
| 8-K · Current report | Nov 6, 2024 | Results | SEC |
| 10-Q · Quarterly report | Nov 6, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2024 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 4, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Oct 31, 2024 | Acquisition or disposal | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 16, 2024 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Sep 20, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Sep 20, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Sep 20, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 8-K · Current report | Aug 28, 2024 | Results | SEC |
| 10-K · Annual report | Aug 28, 2024 | Annual report | SEC |
| 144 · Notice of proposed sale | Aug 13, 2024 | Other filings | SEC |
| 8-K · Current report | Jul 30, 2024 | Current report | SEC |
| 8-K · Current report | Jul 9, 2024 | Material contract | SEC |
| 144 · Notice of proposed sale | May 13, 2024 | Other filings | SEC |
| 8-K · Current report | May 8, 2024 | Results | SEC |
| 10-Q · Quarterly report | May 8, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2024 | Current report | SEC |
| 8-K · Current report | Apr 29, 2024 | Material contract | SEC |
| 144 · Notice of proposed sale | Mar 5, 2024 | Other filings | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 9, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 9, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Feb 8, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 7, 2024 | Results | SEC |
| 10-Q · Quarterly report | Feb 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Feb 6, 2024 | Current report | SEC |
| 8-K · Current report | Feb 6, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 19, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Jan 10, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Dec 8, 2023 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Dec 5, 2023 | Other filings | SEC |
| 8-K · Current report | Nov 8, 2023 | Results | SEC |
| 10-Q · Quarterly report | Nov 8, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 7, 2023 | Meeting outcome | SEC |
| 8-K · Current report | Nov 7, 2023 | Current report | SEC |
| 8-K · Current report | Nov 6, 2023 | Current report | SEC |
| ARS · Annual report to shareholders | Sep 15, 2023 | Annual report | SEC |
| DEFA14A · Additional proxy material | Sep 15, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Sep 15, 2023 | Meeting notice | SEC |
| 144 · Notice of proposed sale | Sep 5, 2023 | Other filings | SEC |
| 8-K · Current report | Sep 5, 2023 | Management or board change | SEC |
| 8-K · Current report | Aug 30, 2023 | Results | SEC |
| 10-K · Annual report | Aug 30, 2023 | Annual report | SEC |
| 8-K · Current report | Jul 25, 2023 | Current report | SEC |
| 3 · Initial statement of ownership | Jul 7, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2023 | Insider trade | SEC |
| 8-K · Current report | Jul 6, 2023 | Management or board change | SEC |
| 8-K · Current report | Jun 16, 2023 | Material contract | SEC |
| SC 13D/A · Big-stake notice, amended | Jun 8, 2023 | Big-stake notice | SEC |
| 8-K · Current report | May 3, 2023 | Results | SEC |
| 10-Q · Quarterly report | May 3, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 1, 2023 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Mar 7, 2023 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Feb 13, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Feb 8, 2023 | Results | SEC |
| 10-Q · Quarterly report | Feb 8, 2023 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Feb 8, 2023 | Insider trade | SEC |
This page holds 200 of 774 filings. Open Filings
Cap table
Built by 6ix from Phibro Animal Health Corporation’s releases
- Common shares
- 21,105,569
- Fully diluted
- 21,105,569
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 21,105,569 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 21,105,569 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joyce J Lee Other companies: Elanco Animal Health Incorporated (Ex VP Prs US Pet Hlth Com Op · Aug 1, 2020 – Nov 30, 2021 · Past); Balchem Corporation (Director · Sep 12, 2019 – Feb 8, 2024 · Past); Zoetis Inc. (Executive Vice President · Jan 31, 2013 – Apr 9, 2015 · Past) | Director · Jan 21, 2025 – Jan 21, 2025 · Past |
| Carol Wrenn Other companies: Heska Corporation (Director · Jan 1, 2013 – May 3, 2018 · Past); Alpharma Inc (See Remarks · Dec 31, 2005 – Dec 29, 2008 · Past) | Director · Apr 10, 2014 – Apr 16, 2014 · Past |
| Kenneth Hanau Other companies: Diversey Holdings Ltd (Director · Mar 25, 2021 – Jul 5, 2023 · Past); Triton International Ltd. (Director · Jul 12, 2016 – Sep 28, 2023 · Past) | Director · Apr 10, 2014 – Apr 10, 2014 · Past |
| Alejandro Bernal Other companies: Zoetis Inc. (Executive Vice President · Jan 31, 2013 – Feb 27, 2018 · Past) | Director · Feb 6, 2023 – Feb 6, 2023 · Past |
| Damian Finio Other companies: Teligent Inc (CFO · Apr 1, 2014 – Mar 2, 2020 · Past) | Chief Financial Officer · Nov 15, 2020 – Nov 15, 2020 · Past |
| Glenn David Other companies: Zoetis Inc. (Executive Vice President · Apr 22, 2014 – Jan 13, 2023 · Past) | Chief Financial Officer · Since at least Feb 9, 2024 |
| Anthony Andolino | See Remarks · Since at least Mar 1, 2018 |
| Daniel A Welch | Sr VP, Human Resources · Apr 10, 2014 – Mar 14, 2017 · Past |
| Daniel M. Bendheim | President and Chief Executive Officer · Since at least Aug 14, 2017 |
| David C Storbeck | VP Finance and Treasurer · Apr 10, 2014 – Apr 10, 2014 · Past |
All 26 people
| Person | Seat |
|---|---|
| Dean J Warras | Pres Animal Health & Nutr N.A. · Sep 16, 2015 – Jan 15, 2019 · Past |
| E Thomas Corcoran | Director · Since at least Apr 10, 2014 |
| Gerald K Carlson | Director · Apr 10, 2014 – Sep 11, 2017 · Past |
| Jack Bendheim | Executive Chairman, Director · Since at least Apr 10, 2014 |
| Jack C. Bendheim | Executive Chairman and Chairman of the Board of Directors · Since at least Feb 4, 2026 |
| Jonathan Bendheim | Executive Vice President, Talent, Technology and Business Development · Since at least Aug 27, 2018 |
| Judith A. Weinstein | Senior Vice President, General Counsel and Corporate Secretary · Since at least Jul 1, 2023 |
| Larry Lee Miller | Chief Operating Officer · Since at least Apr 10, 2014 |
| Larry L. Miller | Chief Operating Officer · Since at least Sep 9, 2026 |
| Lisa A. Escudero | Senior Vice President, Human Resources · Since at least Mar 16, 2017 |
| Mona Desai | Vice President and Corporate Controller · Since at least Nov 5, 2026 |
| Patrick Rodriguez | Vice President Finance and Treasurer · Since at least Jan 12, 2026 |
| Richard G Johnson | Chief Financial Officer · Apr 10, 2014 – Sep 13, 2017 · Past |
| Robin Aukerman | President,North America Region · May 20, 2019 – May 20, 2019 · Past |
| Sam Gejdenson | Director · Apr 10, 2014 – Apr 10, 2014 · Past |
| Thomas G Dagger | SVP, Gen Counsel & Corp Secy · Apr 10, 2014 – Jun 1, 2017 · Past |
Log in to ask 6ix AI your own questions about Phibro Animal Health Corporation.